Lodotra®

DRUG2 trials

Sponsors

Mundipharma Research Limited, Mundipharma Korea Ltd

Conditions

Polymyalgia RheumaticaRheumatoid Arthritis

Phase 3

A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR

TerminatedNCT01821040

Mundipharma Research LimitedPolymyalgia Rheumatica

Start: 2013-03-31End: 2014-04-30Updated: 2018-10-24

Phase 4

Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)

CompletedNCT02072200

Mundipharma Korea LtdRheumatoid Arthritis

Start: 2013-09-30End: 2015-04-30Updated: 2016-08-08